Asthma vs. COPD: What's the Difference and How Are They Treated?

Both asthma and COPD cause breathlessness and wheezing - but they are different diseases with different causes, different progressions and different treatments. Confusing them can lead to years of inadequate care: the wrong inhaler, missed warning signs and a condition that quietly worsens while appearing to be managed. In the UAE, where dust, humidity and air quality vary dramatically by season, getting the correct diagnosis is not a formality - it is the difference between controlling your breathing and losing ground to it. A spirometry test at our Sharjah pulmonology clinic can distinguish the two in under 20 minutes.

Key Takeaways

• Asthma and COPD share symptoms - breathlessness, wheezing, chest tightness - but they are fundamentally different conditions requiring different treatment strategies.
  
• Asthma is largely reversible; airways can return to near-normal between episodes with the right medication.
  
• COPD involves permanent structural lung damage that does not fully reverse, though it can be slowed and well managed.
  
• You can have both at the same time - a condition called ACOS (Asthma-COPD Overlap Syndrome) that requires specialist diagnosis.
  
• A single spirometry test with reversibility testing is the definitive way to tell the two conditions apart.

Asthma vs. COPD at a Glance

This table covers the most clinically significant differences. If you read nothing else, read this - then speak to one of our specialists.

What is Asthma?

Asthma is a chronic inflammatory condition of the airways in which the lining of the bronchial tubes swells, the surrounding muscles tighten and excess mucus is produced. This narrowing makes it difficult to breathe - particularly to exhale - and typically occurs in episodes rather than as a constant state.

The critical distinction is reversibility. Asthma is reversible - airways can return to normal between episodes, either spontaneously or with treatment. This is what separates it from COPD at a biological level.

In the UAE, asthma triggers are particularly prevalent. Fine particulate matter from desert dust and haboob storms irritates sensitised airways almost immediately. Seasonal pollen from grasses and date palms peaks between February and May. The shift between air-conditioned interiors and the humid summer heat outdoors creates sudden temperature changes that can provoke bronchospasm. Even the cold, dry air from overpowered air conditioning units - common in Sharjah homes, offices and malls - is a recognised asthma trigger that many patients do not connect to their symptoms.

Asthma is one of the most common chronic conditions in the UAE, with prevalence estimated to be higher among children than in most comparable countries. Proper diagnosis and an up-to-date management plan are essential, particularly before summer and the haboob season.

What is COPD?

COPD - chronic obstructive pulmonary disease - is a progressive condition in which the airways are permanently damaged and narrowed by long-term exposure to irritants, most commonly cigarette smoke, but also occupational dust, shisha and chronic air pollution. Unlike asthma, the airflow obstruction in COPD does not significantly reverse, because the structural tissue of the lungs has been altered over years.

For a full explanation of COPD symptoms, stages and how it is diagnosed at our clinic, read our detailed guide: How to Know If You Have COPD: A Sharjah Pulmonologist Explains the Warning Signs.

Can You Have Both Asthma and COPD?

Yes - and more commonly than many patients and even some clinicians realise.

ACOS, or Asthma-COPD Overlap Syndrome, is the term used when a patient has features of both conditions simultaneously: the reversible, trigger-sensitive airways of asthma combined with the fixed structural damage and progressive decline of COPD. ACOS is associated with more frequent flare-ups, worse quality of life and faster decline than either condition alone.

Diagnosing ACOS requires more than a standard spirometry reading. It calls for a detailed clinical history, allergy testing, careful review of reversibility data and often a high-resolution CT scan to assess the extent of underlying lung damage. This is precisely the kind of nuanced assessment that benefits from specialist input rather than general practice management - and one of the most common reasons patients are referred to our pulmonology team in Sharjah.

How We Distinguish Asthma from COPD at Our Clinic

The definitive tool for separating asthma from COPD is spirometry with reversibility testing - and it is available at Sheikh Sultan Bin Zayed Hospital without referral.

The test itself is straightforward. You breathe into a device that measures how much air you can exhale and how quickly. We then administer a bronchodilator inhaler and repeat the measurement 15 to 20 minutes later. The comparison tells us everything:

In asthma, lung function typically improves significantly after the bronchodilator - the obstruction is reversible.

In COPD, the improvement is minimal or absent - the obstruction is fixed.

In ACOS, there is partial but meaningful improvement, alongside a clinical picture that does not fit neatly into either category alone.

The full assessment, including clinical review and spirometry with reversibility testing, takes under 20 minutes for the breathing component. We may also recommend a chest X-ray or CT scan to support the diagnosis and rule out other conditions. The goal is not a label - it is a precise understanding of what is happening in your lungs so that treatment can be targeted correctly from the outset.

Treatment: Why Getting the Diagnosis Right Matters

Asthma and COPD share some medications - particularly inhaled bronchodilators and corticosteroids - but the treatment philosophy is fundamentally different, and using the wrong approach can cause real harm.

For asthma, the treatment goal is to eliminate attacks entirely. This means identifying and avoiding personal triggers, using a daily preventer inhaler containing an inhaled corticosteroid to keep inflammation under control, and having a reliever inhaler on hand for breakthrough symptoms. When asthma is well managed, many patients are virtually symptom-free between episodes.

For COPD, the goal shifts. Because the underlying damage cannot be reversed, treatment focuses on slowing progression, reducing the frequency and severity of flare-ups and preserving the lung function that remains. Long-acting bronchodilators - both alone and in combination with inhaled steroids - are the mainstay. Pulmonary rehabilitation is one of the most effective interventions available and remains significantly underused. Smoking cessation is non-negotiable for any COPD patient who still smokes; it is the single most impactful step in slowing the disease.

The danger of misdiagnosis runs in both directions. A COPD patient treated for asthma alone may not receive the long-acting bronchodilators and rehabilitation that slow progression. An asthma patient incorrectly labelled with COPD may be undertreated for the reversible inflammatory component and experience more attacks than necessary.

Getting it right at the start saves years.